C. Michael Stein

5.9k total citations
109 papers, 4.2k citations indexed

About

C. Michael Stein is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Michael Stein has authored 109 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Michael Stein's work include Pharmacogenetics and Drug Metabolism (14 papers), Systemic Lupus Erythematosus Research (12 papers) and Heart Rate Variability and Autonomic Control (10 papers). C. Michael Stein is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Systemic Lupus Erythematosus Research (12 papers) and Heart Rate Variability and Autonomic Control (10 papers). C. Michael Stein collaborates with scholars based in United States, Canada and Israel. C. Michael Stein's co-authors include Cecilia P. Chung, Alastair J.J. Wood, Richard B. Kim, Wayne A. Ray, Hong‐Guang Xie, Katherine T. Murray, James R. Daugherty, Chim C. Lang, Dan M. Roden and William O. Cooper and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

C. Michael Stein

109 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Michael Stein United States 35 1.2k 577 539 535 512 109 4.2k
David J. Graham United States 33 1.6k 1.3× 982 1.7× 369 0.7× 654 1.2× 298 0.6× 115 5.6k
Raymond G. Schlienger Switzerland 34 759 0.6× 565 1.0× 329 0.6× 261 0.5× 349 0.7× 81 4.0k
Philippe Lechat France 42 3.7k 3.0× 952 1.6× 198 0.4× 806 1.5× 560 1.1× 168 7.3k
Gerard A. Rongen Netherlands 37 1.5k 1.2× 760 1.3× 860 1.6× 880 1.6× 100 0.2× 139 4.8k
Gerald A. Faich United States 29 899 0.7× 821 1.4× 428 0.8× 279 0.5× 380 0.7× 75 5.0k
Renke Maas Germany 47 2.9k 2.3× 670 1.2× 136 0.3× 908 1.7× 183 0.4× 156 6.7k
C. Michael Stein United States 36 2.1k 1.7× 658 1.1× 1.6k 2.9× 1.0k 2.0× 1.7k 3.3× 68 7.0k
Janice B. Schwartz United States 41 1.7k 1.4× 453 0.8× 613 1.1× 2.6k 4.8× 126 0.2× 146 7.7k
Annie Fourrier‐Réglat France 31 504 0.4× 303 0.5× 261 0.5× 338 0.6× 147 0.3× 125 3.7k
Emanuel Raschi Italy 34 851 0.7× 436 0.8× 331 0.6× 636 1.2× 64 0.1× 169 4.1k

Countries citing papers authored by C. Michael Stein

Since Specialization
Citations

This map shows the geographic impact of C. Michael Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Michael Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Michael Stein more than expected).

Fields of papers citing papers by C. Michael Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Michael Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Michael Stein. The network helps show where C. Michael Stein may publish in the future.

Co-authorship network of co-authors of C. Michael Stein

This figure shows the co-authorship network connecting the top 25 collaborators of C. Michael Stein. A scholar is included among the top collaborators of C. Michael Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Michael Stein. C. Michael Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Wayne A., Cecilia P. Chung, C. Michael Stein, et al.. (2024). Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban. JAMA. 331(18). 1565–1565. 12 indexed citations
2.
Ray, Wayne A., Cecilia P. Chung, C. Michael Stein, et al.. (2023). Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation. Annals of Internal Medicine. 176(6). 769–778. 15 indexed citations
3.
4.
5.
Liu, Ge, Lan Jiang, V. Eric Kerchberger, et al.. (2023). The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach. Clinical and Translational Science. 16(3). 489–501. 5 indexed citations
6.
Wells, Quinn S., Minoo Bagheri, Aaron W. Aday, et al.. (2021). Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults. Circulation Genomic and Precision Medicine. 14(5). e003341–e003341. 14 indexed citations
7.
Zheng, Neil S., Cosby A. Stone, Lan Jiang, et al.. (2021). High-throughput framework for genetic analyses of adverse drug reactions using electronic health records. PLoS Genetics. 17(6). e1009593–e1009593. 7 indexed citations
8.
Ray, Wayne A., Cecilia P. Chung, Katherine T. Murray, et al.. (2021). Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study. PLoS Medicine. 18(7). e1003709–e1003709. 19 indexed citations
9.
Zheng, Neil S., Jeremy L. Warner, Travis Osterman, et al.. (2020). A retrospective approach to evaluating potential adverse outcomes associated with delay of procedures for cardiovascular and cancer-related diagnoses in the context of COVID-19. Journal of Biomedical Informatics. 113. 103657–103657. 16 indexed citations
10.
Bajaj, Archna, Chengxiang Qiu, Aeron Small, et al.. (2020). Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. Kidney International. 97(5). 1032–1041. 17 indexed citations
11.
Reese, Tyler, Alyson L. Dickson, Megan M. Shuey, et al.. (2019). Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burden. Lupus. 28(8). 954–960. 6 indexed citations
12.
Smit, Roelof A. J., Stella Trompet, Aaron Leong, et al.. (2019). Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study. The Pharmacogenomics Journal. 20(3). 462–470. 17 indexed citations
13.
14.
Mosley, Jonathan D., John S. Witte, Emma K. Larkin, et al.. (2016). Identifying genetically driven clinical phenotypes using linear mixed models. Nature Communications. 7(1). 11433–11433. 8 indexed citations
15.
Chung, Cecilia P., S. Todd Callahan, William O. Cooper, et al.. (2015). Development of an algorithm to identify serious opioid toxicity in children. BMC Research Notes. 8(1). 293–293. 20 indexed citations
16.
Gong, Inna Y., Ute I. Schwarz, Natalie Crown, et al.. (2011). Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation. PLoS ONE. 6(11). e27808–e27808. 62 indexed citations
17.
Haas, David W., Tebeb Gebretsadik, Gail Mayo, et al.. (2009). Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans. The Journal of Infectious Diseases. 199(6). 872–880. 88 indexed citations
18.
Rho, Young Hee, Annette Oeser, Cecilia P. Chung, Ginger L. Milne, & C. Michael Stein. (2009). Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors. PubMed. 2(2). 34–40. 66 indexed citations
19.
Sofowora, G., Iqbal Singh, Huai B. He, Alastair J.J. Wood, & C. Michael Stein. (2005). Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women. Clinical Autonomic Research. 15(3). 193–199. 6 indexed citations
20.
Lang, Chim C., C. Michael Stein, Huai B. He, & Alastair J.J. Wood. (1996). Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects*. Clinical Pharmacology & Therapeutics. 59(6). 668–674. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David J. Graham Breakdown of academic impact, for papers by Raymond G. Schlienger Breakdown of academic impact, for papers by Philippe Lechat Breakdown of academic impact, for papers by Gerard A. Rongen Breakdown of academic impact, for papers by Gerald A. Faich Breakdown of academic impact, for papers by Renke Maas Breakdown of academic impact, for papers by C. Michael Stein Breakdown of academic impact, for papers by Janice B. Schwartz Breakdown of academic impact, for papers by Annie Fourrier‐Réglat Breakdown of academic impact, for papers by Emanuel Raschi
Rankless by CCL
2026